Trials / Completed
CompletedNCT00353392
Q-Switched Nd:YAG in Macular Amyloidosis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.
Detailed description
We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Laser Therapy |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2006-07-01
- Completion
- 2006-08-01
- First posted
- 2006-07-18
- Last updated
- 2013-12-19
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00353392. Inclusion in this directory is not an endorsement.